RedHill Biopharma (RDHL) Debt Ratio (2020 - 2022)

RedHill Biopharma (RDHL) has 3 years of Debt Ratio data on file, last reported at 0.73 in Q4 2022.

• Debt Ratio for Q4 2022 came in at 0.73, down 21.43% year-over-year; the trailing twelve-month figure through Dec 2022 was 0.73 (down 21.43% YoY), and the FY2022 annual result was 0.73, down 21.43% from the prior year.
• Debt Ratio was little changed at 0.73 in Q4 2022 per RDHL's latest filing, from 0.72 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.92 in Q4 2021 and troughed at 0.37 in Q1 2021.
• A 3-year average of 0.59 and a median of 0.51 in 2022 frame the typical range for Debt Ratio.
• The sharpest annual moves came in 2021 and 2022: Debt Ratio tumbled 31.18% in 2021, then soared 61.61% in 2022.
• A 3-year view of Debt Ratio shows it stood at 0.9 in 2020, then grew by 2.21% to 0.92 in 2021, then slipped by 21.43% to 0.73 in 2022.
• Business Quant data shows RDHL's Debt Ratio at 0.73 in Q4 2022, 0.72 in Q3 2022, and 0.51 in Q2 2022.